Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium (SABCS)
Eagle-Tribune -

Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTD

Related Articles

Latest in News

More from Eagle-Tribune | region Crofelemer Breast cancer Cancer treatment Diarrhea San Antonio Breast Cancer Symposium